Resultat från klinisk multicenterstudie med HBP-test publicerade i Critical Care Medicine
August 27, 2015 06:41 ET
|
Hansa Medical AB
Resultat från en klinisk multicenterstudie med prover från akutkliniker i
Sverige, USA och Kanada insamlade under perioden 2011–2014 har publicerats av
Critical Care Medicine på tidskriftens...
Results from a clinical multicenter trial with HBP-assay published in Critical Care Medicine
August 27, 2015 06:40 ET
|
Hansa Medical AB
Results from a clinical multicenter trial with samples from Emergency
Departments in Sweden, USA and Canada collected during 2011-2014 have been
published online ahead of print by the scientific...
Hansa Medical Interim report January – June 2015
August 25, 2015 02:00 ET
|
Hansa Medical AB
January – June 2015 in summary
Operations Summary
Q1
Phase II clinical study of IdeS in highly sensitized patients awaiting kidney
transplantation successfully completed
Cooperation initiated with...
Hansa Medical AB (publ) - Delårsrapport 1 januari - 30 juni 2015
August 25, 2015 02:00 ET
|
Hansa Medical AB
Sammanfattning av perioden januari – juni 2015
Sammanfattning av verksamheten
Kvartal 1
Den kliniska fas II-studien avseende IdeS i högsensitiserade patienter på
väntelista för njurtransplantation...
First patient in IdeS study at Cedars-Sinai Medical Center in Los Angeles receives kidney transplantation
August 11, 2015 02:00 ET
|
Hansa Medical AB
Hansa Medical AB (publ) today announced that the first patient in an
investigator-sponsored Phase II clinical study at Cedars-Sinai Medical Center in
Los Angeles, California, has been treated with...
Den första patienten i IdeS-studien vid Cedars-Sinai Medical Center i Los Angeles har njurtransplanterats
August 11, 2015 02:00 ET
|
Hansa Medical AB
Hansa Medical AB (publ) tillkännager idag att den första patienten i en klinisk
fas II-studie sponsrad av Professor Stanley Jordan vid Cedars-Sinai Medical
Center i Los Angeles har blivit doserad med...
Positive IdeS phase I data published in scientific journal PLOS ONE
July 16, 2015 02:00 ET
|
Hansa Medical AB
Hansa Medical AB (publ) today announced that the results from the phase I trial
of its candidate drug have been published in PLOS ONE
(http://dx.plos.org/10.1371/journal.pone.0132011).
The trial was a...
IdeS fas I-data publicerade i den vetenskapliga tidskriften PLOS ONE
July 16, 2015 02:00 ET
|
Hansa Medical AB
Hansa Medical AB (publ) meddelar idag att resultaten från fas I-studien med
läkemedelskandidaten IdeS har publicerats i den vetenskapliga tidskriften PLOS
ONE...
First patient in IdeS phase II study transplanted
June 15, 2015 02:30 ET
|
Hansa Medical AB
Hansa Medical AB (publ) today announced that the first patient after treatment
with IdeS in a recently initiated Phase II study has been transplanted from a
deceased donor.
The phase II study that can...
Första patienten i IdeS fas II-studie transplanterad
June 15, 2015 02:30 ET
|
Hansa Medical AB
Hansa Medical AB (publ) meddelar att den första patienten som behandlats med
IdeS i en nystartad fas II-studie har blivit transplanterad från en avliden
donator.
Studien, som kan inkludera upp till 10...